CEACAM-3/CD66d, His, Human
| $340.00 | |
| Z05162-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
IVD Raw Materials
| $340.00 | |
| Z05162-100 | |
|
|
|
|
|
|
|
|
|
| Ask us a question | |
| Species | Human | ||||
| Protein Construction |
|
||||
| Purity | > 95% as determined by Bis-Tris PAGE | ||||
| Endotoxin Level | Less than 1EU per μg by the LAL method. | ||||
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | ||||
| Expression System | HEK293 | ||||
| Theoretical Molecular Weight | 14.19 kDa | ||||
| Apparent Molecular Weight | Due to glycosylation, the protein migrates to 17-27 kDa based on Bis-Tris PAGE result. | ||||
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | ||||
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | ||||
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
CEACAM-3/CD66d, His, Human on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
Immobilized CEACAM-3/CD66d, His, Human, His Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human CEACAM-7, hFc Tag with the EC50 of 26.0ng/ml determined by ELISA. »
| Target Background | The human granulocyte-specific receptor carcinoembryonic antigen-related cell adhesion molecule (CEACAM)3 is critically involved in the opsonin-independent recognition of several bacterial pathogens. CEACAM3-mediated phagocytosis depends on the integrity of an ITAM-like sequence within the cytoplasmic domain of CEACAM3 and is characterized by rapid stimulation of the GTPase Rac. |
| Synonyms | CEACAM3; CD66d; CGM1; CEA; |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.